Source:http://linkedlifedata.com/resource/pubmed/id/19462052
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2009-5-22
|
pubmed:abstractText |
Pathological amyloid deposits are mixtures of polypeptides and non-proteinaceous species including heparan sulfate proteoglycans and glycosaminoglycans (GAGs). We describe a procedure in which a (13)C-labelled N-acetyl derivative of the GAG heparin ([(13)C-CH(3)]NAcHep) serves as a useful probe for the analysis of GAG-protein interactions in amyloid using solid-state nuclear magnetic resonance (SSNMR) spectroscopy. NAcHep emulates heparin by enhancing aggregation and altering the fibril morphology of Abeta(1-40), one of the beta-amyloid polypeptides associated with Alzheimer's disease, and alpha-synuclein, the major protein component of Lewy bodies associated with Parkinson's disease. (13)C SSNMR spectra confirm the presence of [(13)C-CH(3)]NAcHep in Abeta(1-40) fibril deposits and detect dipolar couplings between the glycan and arginine R(5) at the Abeta(1-40) N-terminus, suggesting that the two species are intimately mixed at the molecular level. This procedure provides a foundation for further extensive investigations of polypeptide-glycan interactions within amyloid fibrils.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Amyloid,
http://linkedlifedata.com/resource/pubmed/chemical/Amyloid beta-Peptides,
http://linkedlifedata.com/resource/pubmed/chemical/Carbon Isotopes,
http://linkedlifedata.com/resource/pubmed/chemical/Heparin,
http://linkedlifedata.com/resource/pubmed/chemical/alpha-Synuclein
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1477-0539
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
7
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2414-20
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:19462052-Alzheimer Disease,
pubmed-meshheading:19462052-Amyloid,
pubmed-meshheading:19462052-Amyloid beta-Peptides,
pubmed-meshheading:19462052-Carbon Isotopes,
pubmed-meshheading:19462052-Heparin,
pubmed-meshheading:19462052-Humans,
pubmed-meshheading:19462052-Nuclear Magnetic Resonance, Biomolecular,
pubmed-meshheading:19462052-Parkinson Disease,
pubmed-meshheading:19462052-alpha-Synuclein
|
pubmed:year |
2009
|
pubmed:articleTitle |
Exploiting a (13)C-labelled heparin analogue for in situ solid-state NMR investigations of peptide-glycan interactions within amyloid fibrils.
|
pubmed:affiliation |
School of Biological Sciences, University of Liverpool, Crown Street, Liverpool, L69 7ZB, United Kingdom.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|